Board members adopted rules on importation of CBD products for use as additives - but would soon have to approve an interim policy creating an exemption from traceability requirements.
The board began rescinding unnecessary interim policies, heard rulemaking updates, and a licensee called for more time to transition from seed-to-sale traceability to weekly reporting.
A public hearing on the implementation of imported CBD rules drew suggested revisions on cannabis product testing standards from the public and a WSDA pesticide official.
Staff provided more specifics on processes and standards for compliance reporting under the Cannabis Central Reporting System (CCRS) and responded to 50 pre-submitted questions.
Following a longer development process than expected, a CR-102 on CBD imports for use as cannabis product additives was presented to board members and gained their approval.
The board said farewell to the agency public health education liaison and approved revisions to the scoring regime for criminal history background checks on license application and renewal.
A “real quick” presentation on the implementation of HB 2334 by the Policy and Rules Coordinator included a timeline that would ultimately take months longer than predicted.
A briefing on a proposed Cannabis Central Reporting System (CCRS) provided a glimpse of the agency software project that may replace Washington’s beleaguered traceability regime.
At the end of session, representatives considered two amendments to a bill permitting importation of CBD for use as a cannabis product additive before passing it to the Senate.
An $81 annual fee collected from each cannabis licensee was assessed to pay for oversight of imported CBD additives before committee members recommended the bill for passage.